Přihlásit se Zaregistrujte se zdarma

Dluh/Vlastní kapitál společnosti Shenzhen Chipscreen Biosciences Co

Jaká je hodnota metriky Dluh/Vlastní kapitál společnosti Shenzhen Chipscreen Biosciences Co?

Hodnota metriky Dluh/Vlastní kapitál společnosti Shenzhen Chipscreen Biosciences Co., Ltd. je 0.84

Jaká je definice metriky Dluh/Vlastní kapitál?



Poměr dluhu k vlastnímu kapitálu (debt to equity ratio) udává podíl vlastního kapitálu a cizích zdrojů na financování majetku společnosti.

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

Dluh/Vlastní kapitál společností v sektoru Health Care sektor na SSE ve srovnání se společností Shenzhen Chipscreen Biosciences Co

Čemu se věnuje společnost Shenzhen Chipscreen Biosciences Co?

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.

Firmy s metrikou dluh/vlastní kapitál podobnou společnosti Shenzhen Chipscreen Biosciences Co